opc 12759 has been researched along with epidermal growth factor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, T; Kobayashi, K; Tarnawski, A | 1 |
| Itoh, K; Itoh, S; Shinohara, H | 1 |
2 other study(ies) available for opc 12759 and epidermal growth factor
| Article | Year |
|---|---|
Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action?
Topics: Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal; Epidermal Growth Factor; ErbB Receptors; Fluorescent Antibody Technique; Gene Expression Regulation; Male; Quinolones; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1998 |
Regulation of human corneal epithelial mucins by rebamipide.
Topics: Alanine; Anti-Ulcer Agents; Biomarkers; Blotting, Western; Cell Line; Cell Proliferation; Epidermal Growth Factor; Epithelium, Corneal; ErbB Receptors; Humans; Ki-67 Antigen; Mucin-1; Mucin-4; Mucin-6; Proliferating Cell Nuclear Antigen; Quinolones; Real-Time Polymerase Chain Reaction | 2014 |